Discover

CRIS
Curis, Inc.
0.42
1 x 0.45
1 x 0.44
bid
ask
-
0.10
19.15%
1 @ 05:51 AM
0.42 -0.00 (0.07%)
Ytd-57.36%
1y-80.37%
0.39
day range
0.57
0.18
52 week range
2.01
Open0.52Prev Close0.52Low0.39High0.57Mkt Cap16.45M
Vol4.45MAvg Vol3.24MEPS-0.58P/EN/AForward P/E-0.77
Beta3.35Short Ratio3.96Inst. Own24.37%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1150-d Avg0.50200-d Avg0.981yr Est21.00

CRIS News

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. T

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular se

Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Pre

Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announ

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Gainers INVO Fertility (NASDAQ:IVF) shares moved upwards by 67.3% to $2.08 during Friday's regu

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split
gurufocus.com
Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance

benzinga.com
Curis Shareholders Approve Reverse Stock Split Effect Ratio From 1-For-5 To 1-For-25

Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-494

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split
prnewswire.com
Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance

Eleven sites open for patient enrollment in TakeAim CLL combination study with zanubrutinib; Company

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Atlantic International (NASDAQ:ATLN) shares increased by 41.0% to $1.1 during Thursday'